
Utilizing real-world evidence from electronic health records and pathology to understand cancer progression, drug safety, and patient outcomes beyond traditional trials. .
Analyzing lab data and EHRs to track disease activity in autoimmune conditions where the immune system mistakenly attacks healthy cells, such as lupus or rheumatoid arthritis .
Leveraging patient registries and natural history data to define disease progression for conditions with small patient populations, accelerating the discovery of new therapies.
Studying immune system disorders and vaccine effectiveness through high-security, advanced RWD analysis to detect new therapeutic targets and monitor antibody development.
Integrating imaging data with real-world clinical notes to improve diagnosis and treatment journeys for neurological disorders like Multiple Sclerosis (MS) .
Using real-time epidemiological data and clinical EHRs to monitor outbreaks, analyze vaccine safety, and trace patient journeys.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.